Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-013796
Filing Date
2025-06-05
Accepted
2025-06-05 16:07:01
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3859
  Complete submission text file 0001641172-25-013796.txt   5318
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 18 SPRING ROAD CONCORD MA 01742
Business Address
Ono Richard Dana (Reporting) CIK: 0001595989 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 251027142